The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?

Detalles Bibliográficos
Autor principal: Bitan, Gal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327354/
https://www.ncbi.nlm.nih.gov/pubmed/32617339
http://dx.doi.org/10.21037/atm.2020.01.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327354/
https://www.ncbi.nlm.nih.gov/pubmed/32617339
http://dx.doi.org/10.21037/atm.2020.01.117

Ejemplares similares